Function of a genetically modified human liver cell line that stores, processes and secretes insulin.

DSpace/Manakin Repository

Search OPUS


Advanced Search

Browse

My Account

Show simple item record

dc.contributor.author Tuch, BE
dc.contributor.author Szymanska, B
dc.contributor.author Yao, M
dc.contributor.author Tabiin, MT
dc.contributor.author Gross, DJ
dc.contributor.author Holman, S
dc.contributor.author Swan, MA
dc.contributor.author Humphrey, RK
dc.contributor.author Marshall, GM
dc.contributor.author Simpson, AM
dc.date.accessioned 2009-12-21T02:33:04Z
dc.date.issued 2003-03
dc.identifier.citation Gene therapy, 2003, 10 (6), pp. 490 - 503
dc.identifier.issn 0969-7128
dc.identifier.other C1 en_US
dc.identifier.uri http://hdl.handle.net/10453/4379
dc.description.abstract An alternative approach to the treatment of type I diabetes is the use of genetically altered neoplastic liver cells to synthesize, store and secrete insulin. To try and achieve this goal we modified a human liver cell line, HUH7, by transfecting it with human insulin cDNA under the control of the cytomegalovirus promoter. The HUH7-ins cells created were able to synthesize insulin in a similar manner to that which occurs in pancreatic beta cells. They secreted insulin in a regulated manner in response to glucose, calcium and theophylline, the dose-response curve for glucose being near-physiological. Perifusion studies showed that secretion was rapid and tightly controlled. Removal of calcium resulted in loss of glucose stimulation while addition of brefeldin A resulted in a 30% diminution of effect, indicating that constitutive release of insulin occurred to a small extent. Insulin was stored in granules within the cytoplasm. When transplanted into diabetic immunoincompetent mice, the cells synthesized, processed, stored and secreted diarginyl insulin in a rapid regulated manner in response to glucose. Constitutive release of insulin also occurred and was greater than regulated secretion. Blood glucose levels of the mice were normalized but ultimately became subnormal due to continued proliferation of cells. Examination of the HUH7-ins cells as well as the parent cell line for beta cell transcription factors showed the presence of NeuroD but not PDX-1. PC1 and PC2 were also present in both cell types. Thus, the parent HUH7 cell line possessed a number of endocrine pancreatic features that reflect the common endodermal ancestry of liver and pancreas, perhaps as a result of ontogenetic regression of the neoplastic liver cell from which the line was derived. Introduction of the insulin gene under the control of the CMV promoter induced changes in these cells to make them function to some extent like pancreatic beta cells. Our results support the view that neoplastic liver cells can be induced to become substitute pancreatic beta cells and become a therapy for the treatment of type I diabetes.
dc.format Print
dc.language eng
dc.relation.isbasedon 10.1038/sj.gt.3301911
dc.title Function of a genetically modified human liver cell line that stores, processes and secretes insulin.
dc.type Journal Article
dc.parent Gene therapy
dc.journal.volume 6
dc.journal.volume 10
dc.journal.number 6 en_US
dc.publocation London, England en_US
dc.identifier.startpage 490 en_US
dc.identifier.endpage 503 en_US
dc.cauo.name SCI.Medical and Molecular Biosciences en_US
dc.conference Verified OK en_US
dc.for 0604 Genetics
dc.personcode 940084
dc.percentage 100 en_US
dc.classification.name Genetics en_US
dc.classification.type FOR-08 en_US
dc.description.keywords Animals
dc.description.keywords Humans
dc.description.keywords Mice
dc.description.keywords Tumor Cells, Cultured
dc.description.keywords Carcinoma, Hepatocellular
dc.description.keywords Liver Neoplasms
dc.description.keywords Diabetes Mellitus
dc.description.keywords Insulin
dc.description.keywords Microscopy, Electron
dc.description.keywords Transfection
dc.description.keywords Mice, SCID
dc.description.keywords Genetic Therapy
pubs.embargo.period Not known
pubs.organisational-group /University of Technology Sydney
pubs.organisational-group /University of Technology Sydney/Faculty of Science
pubs.organisational-group /University of Technology Sydney/Strength - Health Technologies
utslib.copyright.status Closed Access
utslib.copyright.date 2015-04-15 12:17:09.805752+10
pubs.consider-herdc true
utslib.collection.history Closed (ID: 3)
utslib.collection.history School of Medical and Molecular Sciences (ID: 341)


Files in this item

This item appears in the following Collection(s)

Show simple item record